BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36795935)

  • 21. Chikungunya virus infection in Aruba: Diagnosis, clinical features and predictors of post-chikungunya chronic polyarthralgia.
    Huits R; De Kort J; Van Den Berg R; Chong L; Tsoumanis A; Eggermont K; Bartholomeeusen K; Ariën KK; Jacobs J; Van Esbroeck M; Bottieau E; Cnops L
    PLoS One; 2018; 13(4):e0196630. PubMed ID: 29709007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of chikungunya virus infection in children from India during 2009-2010: A cross sectional observational study.
    Raghavendhar BS; Ray P; Ratagiri VH; Sharma BS; Kabra SK; Lodha R
    J Med Virol; 2016 Jun; 88(6):923-30. PubMed ID: 26581026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chikungunya and dengue virus infections during pregnancy: seroprevalence, seroincidence and maternal-fetal transmission, southern Thailand, 2009-2010.
    Laoprasopwattana K; Suntharasaj T; Petmanee P; Suddeaugrai O; Geater A
    Epidemiol Infect; 2016 Jan; 144(2):381-8. PubMed ID: 26113247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Chikungunya virus: A reemerging cause of acute febrile illness in the high jungle of northern Peru.
    Aguilar-Luis MA; Watson H; Tarazona-Castro Y; Troyes-Rivera L; Cabellos-Altamirano F; Silva-Caso W; Aquino-Ortega R; Carrillo-Ng H; Zavaleta-Gavidia V; Del Valle-Mendoza J
    PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011787. PubMed ID: 38079402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of antibodies against chikungunya virus in Singapore resident adult population.
    Ang LW; Kam YW; Lin C; Krishnan PU; Tay J; Ng LC; James L; Lee VJM; Goh KT; Ng LFP; Lin RTP
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006163. PubMed ID: 29281644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chikungunya virus infection in Indonesia: a systematic review and evolutionary analysis.
    Harapan H; Michie A; Mudatsir M; Nusa R; Yohan B; Wagner AL; Sasmono RT; Imrie A
    BMC Infect Dis; 2019 Mar; 19(1):243. PubMed ID: 30866835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence survey of Chikungunya virus in Bagan Panchor, Malaysia.
    Ayu SM; Lai LR; Chan YF; Hatim A; Hairi NN; Ayob A; Sam IC
    Am J Trop Med Hyg; 2010 Dec; 83(6):1245-8. PubMed ID: 21118929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of chikungunya virus infection in five hospitals within Anyigba, Kogi State of Nigeria.
    Omatola CA; Onoja BA; Fassan PK; Osaruyi SA; Iyeh M; Samuel MA; Haruna PU
    Braz J Infect Dis; 2020; 24(1):1-6. PubMed ID: 32001210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and Evaluation of an in-House IgM-Capture ELISA for the Detection of Chikungunya and Its Application to a Dengue Outbreak Situation in Kenya in 2013.
    Wasonga C; Inoue S; Kimotho J; Morita K; Ongus J; Sang R; Musila L
    Jpn J Infect Dis; 2015; 68(5):410-4. PubMed ID: 25866119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of an E2 ELISA Methodology to Assess Chikungunya Seroprevalence in Patients from an Endemic Region of Mexico.
    Kim YC; López-Camacho C; Garcia-Larragoiti N; Cano-Mendez A; Hernandez-Flores KG; Domínguez-Alemán CA; Mar MA; Vivanco-Cid H; Viveros-Sandoval ME; Reyes-Sandoval A
    Viruses; 2019 May; 11(5):. PubMed ID: 31052472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of Anti-Chikungunya Virus Antibodies in Children and Adults in Managua, Nicaragua, After the First Chikungunya Epidemic, 2014-2015.
    Kuan G; Ramirez S; Gresh L; Ojeda S; Melendez M; Sanchez N; Collado D; Garcia N; Mercado JC; Gordon A; Balmaseda A; Harris E
    PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004773. PubMed ID: 27322692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of chikungunya virus infection among HIV-infected adults in French Caribbean Islands of Martinique and Guadeloupe in 2015: A cross-sectional study.
    Curlier E; Fagour L; Herrmann-Storck C; Staelen A; Vingadassalom I; Breurec S; Abel S; Pierre-François S; Jean-Marie J; Laouénan C; Césaire R; Hoen B; Cabié A
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009267. PubMed ID: 33836004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of Chikungunya virus circulation in the Terai region of Nepal in 2014 and 2015.
    Pandey K; Pandey BD; Chaurasiya RR; Thakur M; Neupane B; Shah Y; Ngwe Tun MM; Morita K
    Trans R Soc Trop Med Hyg; 2017 Jul; 111(7):294-299. PubMed ID: 29165625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus.
    Fumagalli MJ; de Souza WM; Espósito DLA; Silva A; Romeiro MF; Martinez EZ; da Fonseca BAL; Figueiredo LTM
    Virol J; 2018 Jul; 15(1):112. PubMed ID: 30041676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological and Molecular Epidemiology of Chikungunya Virus Infection in Vietnam, 2017-2019.
    Nguyen TV; Ngwe Tun MM; Cao MT; Dao HM; Luong CQ; Huynh TKL; Nguyen TTT; Hoang TND; Morita K; Le TQM; Pham QD; Takamatsu Y; Hasebe F
    Viruses; 2023 Oct; 15(10):. PubMed ID: 37896842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re-emergence of Chikungunya virus infection in Eastern India.
    Sengupta S; Mukherjee S; Haldar SK; Bhattacharya N; Tripathi A
    Braz J Microbiol; 2020 Mar; 51(1):177-182. PubMed ID: 31898249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Multidisciplinary Investigation of the First Chikungunya Virus Outbreak in Matadi in the Democratic Republic of the Congo.
    De Weggheleire A; Nkuba-Ndaye A; Mbala-Kingebeni P; Mariën J; Kindombe-Luzolo E; Ilombe G; Mangala-Sonzi D; Binene-Mbuka G; De Smet B; Vogt F; Selhorst P; Matungala-Pafubel M; Nkawa F; Vulu F; Mossoko M; Pukuta-Simbu E; Kinganda-Lusamaki E; Van Bortel W; Wat'senga-Tezzo F; Makiala-Mandanda S; Ahuka-Mundeke S
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Persistence of Chikungunya Virus-Associated Manifestations and Anti-Chikungunya Virus Antibody in Southern Thailand: 5 Years After an Outbreak in 2008-2009.
    Ninla-Aesong P; Mitarnun W; Noipha K
    Viral Immunol; 2020 Mar; 33(2):86-93. PubMed ID: 31976828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective investigation of antibodies against chikungunya virus (CHIKV) in serum from febrile patients in Mozambique, 2009-2015: Implications for its prevention and control.
    Antonio VS; Amade NA; Muianga AF; Ali S; Monteiro V; Mula F; Chelene I; Oludele J; Chongo I; José A; Augusto O; Gudo ES
    PLoS One; 2019; 14(3):e0213941. PubMed ID: 30897135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low chikungunya virus seroprevalence two years after emergence in Fiji.
    Aubry M; Kama M; Henderson AD; Teissier A; Vanhomwegen J; Mariteragi-Helle T; Paoaafaite T; Manuguerra JC; Christi K; Watson CH; Lau CL; Kucharski AJ; Cao-Lormeau VM
    Int J Infect Dis; 2020 Jan; 90():223-225. PubMed ID: 31689529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.